Biostage, Inc. Discusses Potential Clinical Trials for Their Next-Generation Esophageal Implants episode artwork

EPISODE · Nov 25, 2019 · 10 MIN

Biostage, Inc. Discusses Potential Clinical Trials for Their Next-Generation Esophageal Implants

from Stock Day Media · host Stock Day Media

The Stock Day Podcast welcomed Biostage, Inc. (BSTG)(“the Company”), a bioengineering company that is developing next-generation esophageal implants. CEO of the Company, Jim McGorry, joined Stock Day host Everett Jolly.  Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Episode metadata supplied by the publisher feed · Published Nov 25, 2019

Embed this episode

NOW PLAYING

Biostage, Inc. Discusses Potential Clinical Trials for Their Next-Generation Esophageal Implants

0:00 10:16

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Stock Day Media?

This episode is 10 minutes long.

When was this Stock Day Media episode published?

This episode was published on November 25, 2019.

Can I download this Stock Day Media episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!